Xeris Biopharma Reportedly Draws Takeover Interest — But Firm Says It’s ‘Not For Sale’

Xeris Biopharma (XERS) was in focus on Tuesday after Danish drugmaker Lundbeck reportedly expressed interest in acquiring the Chicago-based biotech firm focused on rare-disease treatments.According to a Bloomberg report on Tuesday, Lundbeck has been working with advisers to explore a potential take…